Such subsets characterized by high sTM concentrations or relatively low sTM concentrations and low VCAM-1 concentrations may represent a potential subgroup for enrichment in clinical trials for interventions aimed at halting disease progression, as underscored by the Pediatric Acute Lung Injury Consensus Conference guidelines.27 Here, VCAM1 is linked to acute lung injury.